Key result
Preoperative coronary revascularization fails to reduce long-term mortality before elective vascular surgery.
Why the study?
Does coronary-artery revascularization before elective major vascular surgery reduce long-term mortality in patients with clinically significant coronary artery disease?
RCT (n=510)
Randomly assigned
Yes
Does coronary-artery revascularization before elective major vascular surgery reduce long-term mortality in patients with clinically significant coronary artery disease?
Prophylactic coronary-artery revascularization before elective major vascular surgery in patients with stable cardiac symptoms does not improve long-term mortality or reduce postoperative myocardial infarction.
Answers are grounded in this paper and cite their sources.
Revascularization before elective vascular surgery should not be routine in stable CAD; challenges prior practice and confirms no long-term mortality benefit.
BACKGROUND: The benefit of coronary-artery revascularization before elective major vascular surgery is unclear. METHODS: We randomly assigned patients at increased risk for perioperative cardiac complications and clinically significant coronary artery disease to undergo either revascularization or no revascularization before elective major vascular surgery. The primary end point was long-term mortality. RESULTS: Of 5859 patients scheduled for vascular operations at 18 Veterans Affairs medical centers, 510 (9 percent) were eligible for the study and were randomly assigned to either coronary-artery revascularization before surgery or no revascularization before surgery. The indications for a vascular operation were an expanding abdominal aortic aneurysm (33 percent) or arterial occlusive disease of the legs (67 percent). Among the patients assigned to preoperative coronary-artery revascularization, percutaneous coronary intervention was performed in 59 percent, and bypass surgery was performed in 41 percent. The median time from randomization to vascular surgery was 54 days in the revascularization group and 18 days in the group not undergoing revascularization (P<0.001). At 2.7 years after randomization, mortality in the revascularization group was 22 percent and in the no-revascularization group 23 percent (relative risk, 0.98; 95 percent confidence interval, 0.70 to 1.37; P=0.92). Within 30 days after the vascular operation, a postoperative myocardial infarction, defined by elevated troponin levels, occurred in 12 percent of the revascularization group and 14 percent of the no-revascularization group (P=0.37). CONCLUSIONS: Coronary-artery revascularization before elective vascular surgery does not significantly alter the long-term outcome. On the basis of these data, a strategy of coronary-artery revascularization before elective vascular surgery among patients with stable cardiac symptoms cannot be recommended.
No takes yet. Share an insight, caveat, or question.
McFalls et al. (2004) conducted an RCT in Clinically significant coronary artery disease in patients scheduled for elective major vascular surgery (abdominal aortic aneurysm or lower extremity arterial occlusive disease) (n=510). Preoperative coronary-artery revascularization (PCI or CABG) vs. No preoperative coronary-artery revascularization was evaluated on Long-term mortality (RR 0.98, 95% CI 0.70-1.37, p=0.92). Preoperative coronary-artery revascularization before elective major vascular surgery did not reduce long-term mortality compared with no revascularization.
Synapse has enriched 10 related papers. Consider them for comparative context: